journal article·2024-09Open access

Protosappanin A Protects DOX‐Induced Myocardial Injury and Cardiac Dysfunction by Targeting ACSL4/FTH1 Axis‐Dependent Ferroptosis

Jingxuan Cui, Yujia Chen, Qiannan Yang, Peng Zhao, Mian Yang, Xiaoqi Wang, Ge Mang, Xiangyu Yan, Di Wang, Zhonghua Tong, Penghe Wang, Yingjin Kong, Naixin Wang, Dongni Wang, Nana Dong, Mingyang Liu, Mingyan E, Maomao Zhang, Bo Yu

Advanced Science· Volume 11· Issue 34

Abstract

Abstract Doxorubicin (DOX) is an effective anticancer agent, but its clinical utility is constrained by dose‐dependent cardiotoxicity, partly due to cardiomyocyte ferroptosis. However, the progress of developing cardioprotective medications to counteract ferroptosis has encountered obstacles. Protosappanin A (PrA), an anti‐inflammatory compound derived from hematoxylin, shows potential against DOX‐induced cardiomyopathy (DIC). Here, it is reported that PrA alleviates myocardial damage and dysfunction by reducing DOX‐induced ferroptosis and maintaining mitochondrial homeostasis. Subsequently, the molecular target of PrA through proteome microarray, molecular docking, and dynamics simulation is identified. Mechanistically, PrA physically binds with ferroptosis‐related proteins acyl‐CoA synthetase long‐chain family member 4 (ACSL4) and ferritin heavy chain 1 (FTH1), ultimately inhibiting ACSL4 phosphorylation and subsequent phospholipid peroxidation, while also preventing FTH1 autophagic degradation and subsequent release of ferrous ions (Fe2+) release. Given the critical role of ferroptosis in the pathogenesis of ischemia‐reperfusion (IR) injury, this further investigation posits that PrA can confer a protective effect against IR‐induced cardiac damage by inhibiting ferroptosis. Overall, a novel pharmacological inhibitor is unveiled that targets ferroptosis and uncover a dual‐regulated mechanism for cardiomyocyte ferroptosis in DIC, highlighting additional therapeutic options for chemodrug‐induced cardiotoxicity and ferroptosis‐triggered disorders.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Signaling Pathways in Disease · Cancer-related molecular mechanisms research · Circular RNAs in diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Cardiology The Second Affiliated Hospital of Harbin Medical University Harbin 150086 China

The Key Laboratory of Myocardial Ischemia Harbin 150086 China

State Key Laboratory of Frigid Zone Cardiovascular Disease Harbin 150086 China

Department of Cardiology Daping Hospital The Third Military Medical Chongqing 400000 China

Department of Cardiology The Fourth Affiliated Hospital of Harbin Medical University Harbin 150086 China

Department of Thoracic Radiotherapy Harbin Medical University Cancer Hospital Harbin China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Heilongjiang Province

References (56)

Show source-provided references
1. 10.1093/annonc/mdn29210.1093/annonc/mdn292 ↗
2. 10.1093/cvr/cvz02310.1093/cvr/cvz023 ↗
3. 10.1093/eurheartj/ehac24410.1093/eurheartj/ehac244 ↗
4. 10.1016/j.cell.2012.03.04210.1016/j.cell.2012.03.042 ↗
5. 10.1038/s41419-020-2298-210.1038/s41419-020-2298-2 ↗
6. 10.1073/pnas.182102211610.1073/pnas.1821022116 ↗
7. 10.1002/advs.20220600710.1002/advs.202206007 ↗
8. 10.1200/JCO.1997.15.4.131810.1200/JCO.1997.15.4.1318 ↗
9. 10.2217/fon-2018-021010.2217/fon-2018-0210 ↗
10. 10.1016/j.transproceed.2008.06.09710.1016/j.transproceed.2008.06.097 ↗
11. 10.1007/s00210-009-0461-510.1007/s00210-009-0461-5 ↗
12. 10.1016/j.phrs.2019.10426910.1016/j.phrs.2019.104269 ↗
13. 10.1161/CIRCULATIONAHA.122.06025710.1161/CIRCULATIONAHA.122.060257 ↗
14. 10.1002/advs.20230185210.1002/advs.202301852 ↗
15. 10.1126/scisignal.abn801710.1126/scisignal.abn8017 ↗
16. 10.1172/jci.insight.16975610.1172/jci.insight.169756 ↗
17. 10.1038/s42003-020-0988-z10.1038/s42003-020-0988-z ↗
18. 10.1038/s41556-021-00818-310.1038/s41556-021-00818-3 ↗
19. 10.1038/nchembio.223910.1038/nchembio.2239 ↗
20. 10.1021/acscentsci.0c0159210.1021/acscentsci.0c01592 ↗
21. 10.1186/s12951-022-01353-510.1186/s12951-022-01353-5 ↗
22. 10.1007/s12012-016-9365-z10.1007/s12012-016-9365-z ↗
23. 10.1016/j.yjmcc.2012.03.00610.1016/j.yjmcc.2012.03.006 ↗
24. 10.1096/fj.201802663R10.1096/fj.201802663R ↗
25. 10.1186/s13045-019-0720-y10.1186/s13045-019-0720-y ↗
26. 10.1038/s41420-022-01183-210.1038/s41420-022-01183-2 ↗
27. 10.1038/s41593-022-01221-310.1038/s41593-022-01221-3 ↗
28. 10.1016/j.redox.2021.10218510.1016/j.redox.2021.102185 ↗
29. 10.1038/s41571-020-00462-010.1038/s41571-020-00462-0 ↗
30. 10.1111/febs.1605910.1111/febs.16059 ↗
31. 10.1038/s41580-020-00324-810.1038/s41580-020-00324-8 ↗
32. 10.1016/j.molcel.2018.10.04210.1016/j.molcel.2018.10.042 ↗
33. 10.3390/life1103022210.3390/life11030222 ↗
34. 10.1016/j.tcb.2023.06.00210.1016/j.tcb.2023.06.002 ↗
35. 10.1038/s41586-021-03539-710.1038/s41586-021-03539-7 ↗
36. 10.1080/15548627.2020.173944710.1080/15548627.2020.1739447 ↗
37. 10.1073/pnas.211739611910.1073/pnas.2117396119 ↗
38. 10.1161/CIRCRESAHA.122.32136910.1161/CIRCRESAHA.122.321369 ↗
39. 10.1038/s41392-022-01004-z10.1038/s41392-022-01004-z ↗
40. 10.1016/j.redox.2023.10285710.1016/j.redox.2023.102857 ↗
41. 10.1038/s41392-022-00917-z10.1038/s41392-022-00917-z ↗
42. 10.2337/db22-055310.2337/db22-0553 ↗
43. 10.1016/j.cellsig.2023.11065510.1016/j.cellsig.2023.110655 ↗
44. 10.1038/s41419-023-05978-810.1038/s41419-023-05978-8 ↗
45. 10.1016/j.envint.2022.10770610.1016/j.envint.2022.107706 ↗
46. 10.1016/j.redox.2022.10245110.1016/j.redox.2022.102451 ↗
47. 10.1038/s41418-022-01046-410.1038/s41418-022-01046-4 ↗
48. 10.1007/s13311-020-00929-z10.1007/s13311-020-00929-z ↗
49. 10.1038/s41418-022-00990-510.1038/s41418-022-00990-5 ↗
50. 10.7150/thno.5411310.7150/thno.54113 ↗
51. 10.1056/NEJM19950629332260210.1056/NEJM199506293322602 ↗
52. 10.1038/s41419-020-02948-210.1038/s41419-020-02948-2 ↗
53. 10.1038/s41467-022-35503-y10.1038/s41467-022-35503-y ↗
54. 10.1093/eurheartj/ehy90310.1093/eurheartj/ehy903 ↗
55. 10.1016/j.redox.2022.10231010.1016/j.redox.2022.102310 ↗
56. 10.1073/pnas.152131611210.1073/pnas.1521316112 ↗